Against radical pain

How CerSci’s non-opioids could treat acute pain and prevent chronic pain

CerSci Therapeutics thinks that by neutralizing peroxynitrite and other free radicals it can treat acute pain and prevent it from becoming chronic, without the potential for abuse and addiction.

CerSci was founded in 2014 to create non-opioid pain drugs, and acquired its lead candidate, CT-044, two years later from Galleon Pharmaceuticals Inc. CerSci co-founder and CSO Scott Dax was previously chief technology officer at Galleon.

The molecule had been identified by Dax while he

Read the full 722 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE